VXRT - Rasio utang marang kapitalisasi buku vaxart.com

Historical debt-to-book capitalization dynamics on GURU.Markets demonstrate the financial stability of Vaxart, Inc. (VXRT), where the value 0.00 describes the current level. Risks are linked to liquidity shortages and dependence on US government subsidies. The brand is valued for its innovative oral vaccines that simplify immunization. Meanwhile, Vaxart, Inc. (VXRT) is optimizing costs by outsourcing production and testing to external contractors.

VXRT (Vaxart) riwayat Utang marang nilai buku saka 04.07.2022 nganti 19.07.2025

Ringkesan rincian data analitis vaxart.com (VXRT)

- rega lan prakiraan konsensus rega:

Rega saham Vaxart|VXRT - Prakiraan konsensus analis

- data kapitalisasi pasar:

Nilai pasar Vaxart, Inc.|VXRT - Nilai Dipunlarasaken Utang lan Kas

- data kapitalisasi buku:

Aset Bersih saben Siji Saham Vaxart|VXRT - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku vaxart.com|VXRT - Total Aset Perusahaan

- data utang lan likuiditas:

Rasio Total Utang marang Ekuitas Vaxart, Inc.|VXRT - Koefisien utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Vaxart|VXRT - Utang perusahaan|Utang-utang marang kapitalisasi buku Vaxart, Inc.

Analisis fundamental perusahaan:Vaxart Corp

Investors must assess the resilience of Vaxart, Inc. (VXRT) within the capital-intensive biotechnology sector. This ratio measures the proportion of borrowed funds relative to equity, determining the level of financial leverage. Analyzing the debt-to-book capitalization ratio helps identify overvaluation of the debt load. Minimizing this metric confirms the funding reliability for the sustainable development of oral vaccines. Reducing debt dependency ensures stable growth without the risk of default.

Karo sapa Vaxart, Inc. saingan